Coca-Cola Co said on Monday it would buy the remaining stake in BodyArmor it did not already own for $5.6 billion, as the soda maker amps up its sports drink portfolio to take on market leader, PepsiCo Inc's Gatorade.
Mexican conglomerate Femsa reported a third-quarter net profit of 14.1 billion pesos ($683.8 million) on Thursday, up from a profit of 3.2 billion during the same quarter last year.
Big global brands Pepsi and Levi Strauss told investors this week they offset inflation with price increases, but rising costs of everything from aluminum to cotton signal tighter times ahead for consumer goods companies.
11 Min Read
RIO DE JANEIRO, May 14 (Reuters) - Brazilian President Jair Bolsonaro, addressing the nation last month in a social media video, touted the latest in a string of unconventional drugs he says can ease the country’s COVID-19 crisis.
Bolsonaro - a vaccine skeptic and promoter of discredited treatments such as hydroxychloroquine - said this new drug, Proxalutamide, would “soon be available to all Brazil.” He invited a little-known Health Ministry official, Helio Angotti, to expand on its promise.
Angotti, an eye doctor with no epidemiological experience, cited a domestic Proxalutamide study showing a 92% decrease in mortality risk among hospitalized COVID-19 patients. It was a dramatic claim amid a global struggle to find effective treatments. He said he aimed to “get it to the Brazilian population as soon as possible.”